Comparison of bisoprolol and low dose hydrochlorothiazide combination with losartan, alone or in combination with hydrochlorothiazide, in the treatment of hypertension: A double blind, randomized, placebo controlled trial

Cardiovascular Reviews and Reports

Volumn 19, Issue 12, 1998, Pages 19-28

  Papademetriou, Vasilios ^a   Neutel, Joel ^b   Narayan, Puneet ^a   Smith, David ^b   Kokkinos, Peter ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Orange County Heart Institute and Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISOPROLOL; BISOPROLOL FUMARATE PLUS HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS LOSARTAN; LOSARTAN; LOSARTAN POTASSIUM;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; DYSPNEA; FEMALE; HEADACHE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL;

EID: 0032406652     PISSN: 01973118     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Publication No. 98-4080; National Institutes of Health. 1997
2. Hansson L, Zanchetti A, Carruther SG, et al. Effects of intensive blood-pressure lowing and low dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet. 1998;351:1755-1762.
3. Frishman WH, Bryzinski BS, Coulson LR, et al. A multifactorial trial design to assess combination therapy in hypertension. Arch Intern Med. 1994:154:1461-1468.
4. Frishman WH, Burris JF, Mroczek WJ, et al. First line therapy option with low-dose bisoprolol fumurate and low dose hydrochlorothiazide in patients with Stage I and Stage II systemic hypertension. J Clin Pharmacol. 1995;35:182-188.
5. Prisant M, Weir MR, Papademetriou V. Low dose combination therapy: An alternative first line to hypertensive treatment. Am Heart J. 1995;130:359-366.
6. Neutel JM, Rolf CN, Valentine SN, et al. Low dose combination therapy as first line treatment of mild-to-moderate hypertension. The efficacy and safety of bisoprolol/HCTZ versus amlodipine, enalapril, and placebo. CVRR. 1996;1-5.
7. Prisant LM, Neutel JM, Papademetriou V, et al. Low dose combination treatment for hypertension versus single drug treatment - bisoprolol/hydrochlorothiazide versus amlodipine, enalapril, and placebo: Combined analysis of comparative studies. Am J Therapeutics. 1998;5:313-322.
8. Papademetriou V, Prisant LM, Neutel JM, et al. Efficacy of low dose combination of bisoprolol/hydrochlorothiazide compared with amlodipine and enalapril in men and women with essential hypertension. Am J Coll Cardiol. 1998;81:1363-1365.
9. Prisant LM, Neutel JM, Ferdinand K. Low dose combination therapy as first line treatment for blacks and nonblacks. J Natl Med Assoc. Submitted 1998.
10. Prescribing Information for Cozaar/Hyzaar. Physicians' Desk Reference. Montvale, New Jersey: Medical Economics Company Inc.; 1998
11. Zachariah PK, Messerli FH, Mroczek W. Low dose bisoprolol/hydrochlorothiazide: An option in first-line antihypertensive treatment. Clin Ther. 1993;15:779-787.
12. Weir MR. A new antihypertensive strategy to minimize dose related side effects: Low dose multimechanism therapy. Adv Ther. 1993;10:293-298.